Philips
Pietro Armigliato is an accomplished leader in cardiovascular research and technology, currently serving as President and Scientific Board Director of the Cardiovascular Laser Society Foundation since February 2024, and as Vice President and General Secretary of the CardioVascular Laser Society since March 2017. With extensive experience spanning over two decades, Pietro has held significant roles including Medical and Clinical Research Director at Philips IGT Delta Hospital, where responsibilities included overseeing clinical trials and marketing activities in Italy. Prior positions involved key leadership roles at Medtronic - Invatec, Sorin Group, AngioDynamics, Cordis Spa, and Johnson & Johnson, focusing on clinical management, research, and marketing in interventional cardiology. Pietro's educational background includes studies at the University of Verona and the University of Barcelona, contributing to a robust expertise in cardiovascular pathologies and innovative laser technologies.
This person is not in any offices
Philips
180 followers
Philips' main purpose is to improve the health and well-being of humankind through innovation. Philips' goal is to improve the lives of 2 billion people by 2025, including 200 million in underserved communities. In 2021, Philips has over 1.8 billion euros invested in R&D and over registered 57,000 patent rights. When it comes to innovation, Philips aims to not do it in isolation - instead, they partner with healthcare providers, start-ups, universities (especially university hospitals), and other companies. Philips has been named by Boston Consulting Group in 2020 as the number 1 MedTech company in the world.